Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monkeypox
Pharma
NIH study shows mpox shot elicits immune response in teens
Interim results of an NIH trial of Bavarian Nordic's Jynneos indicate that it is safe and elicits an immune response in teens.
Kevin Dunleavy
Oct 17, 2024 11:17am
Siga's Tpoxx misses the mark in mpox study amid renewed outbreak
Aug 15, 2024 11:35am
US renews $113M deal with Siga to supply mpox antiviral Tpoxx
Jul 19, 2024 10:35am
Bavarian Nordic begins commercial launch of mpox vaccine in US
Apr 2, 2024 2:00am
Mpox still a risk as new awareness campaigns launch
Aug 10, 2023 10:15am
Bavarian Nordic's mpox vaccine Jynneos up to 86% effective: CDC
May 18, 2023 1:29pm
